Literature DB >> 1592165

Measurement of final container residual moisture in freeze-dried biological products.

J C May1, R M Wheeler, N Etz, A Del Grosso.   

Abstract

The Center for Biologics Evaluation and Research has changed its regulations pertaining to residual moisture in freeze-dried biological products as published in Title 21 of the Code of Federal Regulations for Food and Drugs. The new regulation requires that each lot of dried product be tested for residual moisture and meet and not exceed established limits as specified by an approved method on file in the product license application. The gravimetric or loss-on-drying method is no longer listed as the required method; the 1.0% moisture limit is no longer specifically stated in the regulation. These revisions were made to bring the regulation into line with changes in residual moisture testing methods and the results obtained when new testing methods were applied to the determination of residual moisture. This is illustrated with data for Measles Virus Vaccine Live and Haemophilus b Polysaccharide Vaccine using final container residual moisture test results obtained by the gravimetric, coulometric Karl Fischer, thermogravimetric and thermogravimetric/mass spectrometric methods. Guidelines for the determination of residual moisture in dried biological products have been issued to describe residual moisture test methods and procedures used to set product residual moisture limits. For most products levels of residual moisture should be low, usually from less than 1.0% to 3.0%, so that the viability, immunologic potency and therefore the stability of the product is not compromised over time.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1592165

Source DB:  PubMed          Journal:  Dev Biol Stand        ISSN: 0301-5149


  8 in total

1.  Development of a remote electrode system for monitoring the water content of materials inside a glass vial.

Authors:  Phe Man Suherman; Peter M Taylor; Geoff Smith
Journal:  Pharm Res       Date:  2002-03       Impact factor: 4.200

2.  Characterization of murine monoclonal antibody to tumor necrosis factor (TNF-MAb) formulation for freeze-drying cycle development.

Authors:  X Ma; D Q Wang; R Bouffard; A MacKenzie
Journal:  Pharm Res       Date:  2001-02       Impact factor: 4.200

3.  Real-time in situ monitoring of lysozyme during lyophilization using infrared spectroscopy: dehydration stress in the presence of sucrose.

Authors:  R L Remmele; C Stushnoff; J F Carpenter
Journal:  Pharm Res       Date:  1997-11       Impact factor: 4.200

4.  New Method for Monitoring the Process of Freeze Drying of Biological Materials.

Authors:  Nikolay Alkeev; Stanislav Averin; Svetlana von Gratowski
Journal:  AAPS PharmSciTech       Date:  2015-05-29       Impact factor: 3.246

5.  Freeze-Drying of Proteins.

Authors:  Baolin Liu; Xinli Zhou
Journal:  Methods Mol Biol       Date:  2021

6.  The Production of a Stable Infliximab Powder: The Evaluation of Spray and Freeze-Drying for Production.

Authors:  Gaurav Kanojia; Rimko Ten Have; Arjen Bakker; Koen Wagner; Henderik W Frijlink; Gideon F A Kersten; Jean-Pierre Amorij
Journal:  PLoS One       Date:  2016-10-05       Impact factor: 3.240

7.  Whole genome integrity and enhanced developmental potential in ram freeze-dried spermatozoa at mild sub-zero temperature.

Authors:  Luca Palazzese; Debora Agata Anzalone; Federica Turri; Marco Faieta; Anna Donnadio; Flavia Pizzi; Paola Pittia; Kazutsugu Matsukawa; Pasqualino Loi
Journal:  Sci Rep       Date:  2020-11-02       Impact factor: 4.379

8.  Peptide Isolation via Spray Drying: Particle Formation, Process Design and Implementation for the Production of Spray Dried Glucagon.

Authors:  Frederik J S Doerr; Lee J Burns; Becky Lee; Jeremy Hinds; Rebecca L Davis-Harrison; Scott A Frank; Alastair J Florence
Journal:  Pharm Res       Date:  2020-12-14       Impact factor: 4.200

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.